• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNF4是一种多聚SUMO特异性E3泛素连接酶,是砷诱导的PML降解所必需的。

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.

作者信息

Tatham Michael H, Geoffroy Marie-Claude, Shen Linnan, Plechanovova Anna, Hattersley Neil, Jaffray Ellis G, Palvimo Jorma J, Hay Ronald T

机构信息

Wellcome Trust Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

出版信息

Nat Cell Biol. 2008 May;10(5):538-46. doi: 10.1038/ncb1716. Epub 2008 Apr 13.

DOI:10.1038/ncb1716
PMID:18408734
Abstract

In acute promyelocytic leukaemia (APL), the promyelocytic leukaemia (PML) protein is fused to the retinoic acid receptor alpha (RAR). This disease can be treated effectively with arsenic, which induces PML modification by small ubiquitin-like modifiers (SUMO) and proteasomal degradation. Here we demonstrate that the RING-domain-containing ubiquitin E3 ligase, RNF4 (also known as SNURF), targets poly-SUMO-modified proteins for degradation mediated by ubiquitin. RNF4 depletion or proteasome inhibition led to accumulation of mixed, polyubiquitinated, poly-SUMO chains. PML protein accumulated in RNF4-depleted cells and was ubiquitinated by RNF4 in a SUMO-dependent fashion in vitro. In the absence of RNF4, arsenic failed to induce degradation of PML and SUMO-modified PML accumulated in the nucleus. These results demonstrate that poly-SUMO chains can act as discrete signals from mono-SUMOylation, in this case targeting a poly-SUMOylated substrate for ubiquitin-mediated proteolysis.

摘要

在急性早幼粒细胞白血病(APL)中,早幼粒细胞白血病(PML)蛋白与维甲酸受体α(RAR)融合。这种疾病可用砷有效治疗,砷可通过小泛素样修饰物(SUMO)诱导PML修饰并经蛋白酶体降解。在此,我们证明含RING结构域的泛素E3连接酶RNF4(也称为SNURF)靶向多聚SUMO修饰的蛋白以进行泛素介导的降解。RNF4缺失或蛋白酶体抑制导致混合的、多聚泛素化的、多聚SUMO链的积累。PML蛋白在RNF4缺失的细胞中积累,并且在体外RNF4以SUMO依赖的方式使其泛素化。在缺乏RNF4的情况下,砷未能诱导PML降解,且SUMO修饰的PML在细胞核中积累。这些结果表明,多聚SUMO链可作为与单SUMO化不同的信号,在这种情况下,将多聚SUMO化底物靶向泛素介导的蛋白水解。

相似文献

1
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.RNF4是一种多聚SUMO特异性E3泛素连接酶,是砷诱导的PML降解所必需的。
Nat Cell Biol. 2008 May;10(5):538-46. doi: 10.1038/ncb1716. Epub 2008 Apr 13.
2
Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.砷通过一种由SUMO触发的RNF4/泛素介导的途径降解PML或PML-RARα。
Nat Cell Biol. 2008 May;10(5):547-55. doi: 10.1038/ncb1717. Epub 2008 Apr 13.
3
Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies.砷诱导的 SUMO 依赖性 RNF4 募集到 PML 核体中。
Mol Biol Cell. 2010 Dec;21(23):4227-39. doi: 10.1091/mbc.E10-05-0449. Epub 2010 Oct 13.
4
Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.小泛素样修饰蛋白(SUMO)在RNF4介导的早幼粒细胞白血病蛋白(PML)降解中的作用:PML的SUMO化及其SUMO结合结构域的磷酸化开关调控在活细胞中的解析
J Biol Chem. 2009 Jun 12;284(24):16595-16608. doi: 10.1074/jbc.M109.006387. Epub 2009 Apr 20.
5
Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.PML SUMO 相互作用基序对 RNF4 或三氧化二砷诱导的核 PML 异构体降解的要求。
PLoS One. 2012;7(9):e44949. doi: 10.1371/journal.pone.0044949. Epub 2012 Sep 18.
6
E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.E1B-55K 介导的 RNF4 SUMO 靶向泛素连接酶的调节促进人腺病毒基因表达。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00164-18. Print 2018 Jul 1.
7
Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.阿卡迪亚,一种新型 SUMO 靶向泛素连接酶,参与 PML 的降解。
Mol Cell Biol. 2013 Jun;33(11):2163-77. doi: 10.1128/MCB.01019-12. Epub 2013 Mar 25.
8
SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.SUMO去共轭作用是砷引发的PML泛素化所必需的。
Sci Signal. 2015 Jun 9;8(380):ra56. doi: 10.1126/scisignal.aaa3929.
9
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.三氧化二砷通过直接结合 PML 来控制 PML-RARα 癌蛋白的命运。
Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424.
10
The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.早幼粒细胞白血病蛋白刺激酵母中的小泛素样修饰蛋白缀合。
Oncogene. 2006 May 18;25(21):2999-3005. doi: 10.1038/sj.onc.1209335.

引用本文的文献

1
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiency.端粒SUMO水平影响APB形成途径的选择和ALT效率。
J Cell Biol. 2025 Oct 6;224(10). doi: 10.1083/jcb.202410073. Epub 2025 Sep 3.
2
Production and Purification of SUMO-UBC9 and SUMO-RANGAP1.SUMO-UBC9和SUMO-RANGAP1的制备与纯化。
Methods Mol Biol. 2025;2957:67-82. doi: 10.1007/978-1-0716-4710-3_5.
3
The SUMO Pathway.小泛素样修饰物途径
Methods Mol Biol. 2025;2957:1-15. doi: 10.1007/978-1-0716-4710-3_1.
4
Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation.SIM 结合凹槽突变体的相互作用网络揭示了 SUMO 结合的替代模式以及对 SUMO 缀合的深远影响。
Sci Adv. 2025 May 16;11(20):eadp2643. doi: 10.1126/sciadv.adp2643. Epub 2025 May 14.
5
Ubiquitin-SUMO tag-team wrestles acute promyelocytic leukemia.泛素-类泛素化标签协同作用对抗急性早幼粒细胞白血病。
J Cell Biol. 2025 Jun 2;224(6). doi: 10.1083/jcb.202504010. Epub 2025 May 9.
6
The multifaceted nature of SUMOylation in heart disease and its therapeutic potential.SUMO化修饰在心脏病中的多面性及其治疗潜力。
Mol Cell Biochem. 2025 Apr 27. doi: 10.1007/s11010-025-05286-z.
7
Targeted protein degradation for cancer therapy.用于癌症治疗的靶向蛋白质降解
Nat Rev Cancer. 2025 Apr 25. doi: 10.1038/s41568-025-00817-8.
8
Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networks.诱导与早幼粒细胞白血病蛋白(PML)接近可通过SUMO-泛素网络保护TAR DNA结合蛋白43(TDP-43)不发生聚集。
Nat Chem Biol. 2025 Apr 17. doi: 10.1038/s41589-025-01886-4.
9
Nuclear SUMOylation and Proteotoxic Stress Responses to Metals with Different Ligand Preferences.核小泛素样修饰以及对具有不同配体偏好性的金属的蛋白质毒性应激反应
Chem Res Toxicol. 2025 May 19;38(5):942-953. doi: 10.1021/acs.chemrestox.5c00040. Epub 2025 Apr 17.
10
PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways.来自抗砷患者的PML突变体揭示了SUMO1-TOPORS和SUMO2/3-RNF4降解途径。
J Cell Biol. 2025 Jun 2;224(6). doi: 10.1083/jcb.202407133. Epub 2025 Apr 16.